针对乳腺癌治疗中的黄素的向药物输送系统
Mian Huang1, Bing-Tao Zhai1,2, Yu Fan3
1School of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, 712046, People's Republic of China.
International journal of nanomedicine
|August 3, 2023
概括
黄素 (CUR) 显示出作为乳腺癌治疗的希望,但面临生物可用性挑战. 基于纳米材料的向药物递送系统 (TDDS) 为增强CUR提供了一个解决方案.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
背景情况:
- 乳腺癌 (BC) 是女性癌症相关死亡的主要原因.
- 传统的治疗方法,如化疗和放射治疗,具有显著的副作用.
- 黄中的天然化合物黄 (CUR) 具有抗癌特性,但其生物可用性较差.
研究的目的:
- 审查CUR在乳腺癌中的物理化学特性,生物可用性和抗癌机制.
- 为突出基于CUR的针对性药物递送系统 (TDDS) 在BC治疗中的最新进展.
- 为CUR TDDSs的临床发展提供参考.
主要方法:
- 文献综述,重点关注CUR的特性和BC机制.
- 对CUR各种TDDS的研究分析,包括被动,活性和物理化学方法.
- 强调近期纳米医学研究在BC提供CUR的重点.
主要成果:
- 通过调节细胞内信号通路,CUR显示出抗癌活性.
- 由于CUR的溶解性,稳定性和生物利用性不佳,CUR的治疗潜力受到限制.
- 目前正在开发各种TDDS,包括被动,活性和物理化学,以克服CUR的局限性.
结论:
- 在乳腺癌治疗中,TDDS对于提高CUR的有效性和向性至关重要.
- 基于纳米材料的输送系统为改善CUR治疗指数提供了一个有希望的策略.
- 对CUR TDDS的进一步研究有必要在乳腺癌治疗中进行临床应用.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


